Centre Hospitalier Universitaire Estaing

Clermont-Ferrand, Auvergne 63100

0 studies enrolling now · 4 studies all time

What they study most

Colorectal Cancer, Crohn Disease, NASH - Nonalcoholic Steatohepatitis, Pancreatic Ductal Adenocarcinoma

Studies at this site

• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery — Stopped early
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early